BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Halper-Stromberg E, Gillenwater L, Cruickshank-Quinn C, O'Neal WK, Reisdorph N, Petrache I, Zhuang Y, Labaki WW, Curtis JL, Wells J, Rennard S, Pratte KA, Woodruff P, Stringer KA, Kechris K, Bowler RP. Bronchoalveolar Lavage Fluid from COPD Patients Reveals More Compounds Associated with Disease than Matched Plasma. Metabolites 2019;9:E157. [PMID: 31349744 DOI: 10.3390/metabo9080157] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Dasgupta S, Ghosh N, Bhattacharyya P, Roy Chowdhury S, Chaudhury K. Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview. Crit Rev Clin Lab Sci 2023;60:153-70. [PMID: 36420874 DOI: 10.1080/10408363.2022.2140329] [Reference Citation Analysis]
2 Ma P, Wang M, Wang Y. Gut microbiota: A new insight into lung diseases. Biomedicine & Pharmacotherapy 2022;155:113810. [DOI: 10.1016/j.biopha.2022.113810] [Reference Citation Analysis]
3 Gruzieva O, Jeong A, He S, Yu Z, de Bont J, Pinho MGM, Eze IC, Kress S, Wheelock CE, Peters A, Vlaanderen J, de Hoogh K, Scalbert A, Chadeau-Hyam M, Vermeulen RCH, Gehring U, Probst-Hensch N, Melén E. Air pollution, metabolites and respiratory health across the life-course. Eur Respir Rev 2022;31:220038. [PMID: 35948392 DOI: 10.1183/16000617.0038-2022] [Reference Citation Analysis]
4 Godbole S, Bowler RP. Metabolome Features of COPD: A Scoping Review. Metabolites 2022;12:621. [PMID: 35888745 DOI: 10.3390/metabo12070621] [Reference Citation Analysis]
5 Maniscalco M, Paris D, Cuomo P, Fuschillo S, Ambrosino P, Tramice A, Palomba L, Motta A. Metabolomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath Condensate. Cells 2022;11:344. [DOI: 10.3390/cells11030344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Moitra S, Bandyopadhyay A, Lacy P. Metabolomics of Respiratory Diseases. Handbook of Experimental Pharmacology 2022. [DOI: 10.1007/164_2022_614] [Reference Citation Analysis]
7 Kelly RS, Stewart ID, Bayne H, Kachroo P, Spiro Iii A, Vokonas P, Sparrow D, Weiss ST, Knihtilä HM, Litonjua AA, Wareham NJ, Langenberg C, Lasky-Su JA. Metabolomic differences in lung function metrics: evidence from two cohorts. Thorax 2021:thoraxjnl-2020-216639. [PMID: 34650005 DOI: 10.1136/thoraxjnl-2020-216639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kotlyarov S, Kotlyarova A. Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease. Int J Mol Sci 2021;22:7634. [PMID: 34299266 DOI: 10.3390/ijms22147634] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Armstrong AJS, Quinn K, Fouquier J, Li SX, Schneider JM, Nusbacher NM, Doenges KA, Fiorillo S, Marden TJ, Higgins J, Reisdorph N, Campbell TB, Palmer BE, Lozupone CA. Systems Analysis of Gut Microbiome Influence on Metabolic Disease in HIV-Positive and High-Risk Populations. mSystems 2021;6:e01178-20. [PMID: 34006628 DOI: 10.1128/mSystems.01178-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Armstrong AJ, Quinn K, Fouquier J, Li SX, Schneider JM, Nusbacher NM, Doenges KA, Fiorillo S, Marden TJ, Higgins J, Reisdorph N, Campbell TB, Palmer BE, Lozupone CA. Systems analysis of gut microbiome influence on metabolic disease in HIV and high-risk populations.. [DOI: 10.1101/2021.03.12.435118] [Reference Citation Analysis]
11 Gillenwater LA, Kechris KJ, Pratte KA, Reisdorph N, Petrache I, Labaki WW, O'Neal W, Krishnan JA, Ortega VE, DeMeo DL, Bowler RP. Metabolomic Profiling Reveals Sex Specific Associations with Chronic Obstructive Pulmonary Disease and Emphysema. Metabolites 2021;11:161. [PMID: 33799786 DOI: 10.3390/metabo11030161] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Gai X, Guo C, Zhang L, Zhang L, Abulikemu M, Wang J, Zhou Q, Chen Y, Sun Y, Chang C. Serum Glycerophospholipid Profile in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Front Physiol 2021;12:646010. [PMID: 33658945 DOI: 10.3389/fphys.2021.646010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Gillenwater LA, Pratte KA, Hobbs BD, Cho MH, Zhuang Y, Halper-Stromberg E, Cruickshank-Quinn C, Reisdorph N, Petrache I, Labaki WW, O'Neal WK, Ortega VE, Jones DP, Uppal K, Jacobson S, Michelotti G, Wendt CH, Kechris KJ, Bowler RP. Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules. Netw Syst Med 2020;3:159-81. [PMID: 33987620 DOI: 10.1089/nsm.2020.0009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
14 Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, Wood DLA, Gellatly SL, Shukla SD, Wood LG, Yang IA, Wark PA, Hugenholtz P, Hansbro PM. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun 2020;11:5886. [PMID: 33208745 DOI: 10.1038/s41467-020-19701-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 22.3] [Reference Citation Analysis]